Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transferTimothy J. Smith(Duke University), Aravind Asokan(Duke University)Molecular TherapyMay 6, 202410.1016/j.ymthe.2024.05.004Cited by 33SaveCiteExport RISWatch citationsRelated PapersRescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme|JCI Insight|2020|125Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain|JCI Insight|2016|67Capsid-mediated control of adeno-associated viral transcription determines host range|Cell Reports|2024|28